Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity

INTRODUCTION: This study is based on the results from a Belgian expanded access program in which patients with active refractory and erosive rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab in combination with methotrexate. The objectives of this study were to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, De Keyser, Filip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911854/
https://www.ncbi.nlm.nih.gov/pubmed/20459619
http://dx.doi.org/10.1186/ar2997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911854/
https://www.ncbi.nlm.nih.gov/pubmed/20459619
http://dx.doi.org/10.1186/ar2997

Ejemplares similares